-
IRELAND: “From 800 to 7,000”: Ireland’s Education Appeal Soars Among Indian Students - 8 hours ago
-
TORONTO: Canada Sets Weekly Work Hour Limit For Indian Students At 24 - 1 day ago
-
TORONTO: India strongly protests ‘Khalistan’ slogans at a public event attended by Canadian leaders - May 2, 2024
-
TOKYO: Japan Offers Scholarships To Indian Students Pursuing Research - May 1, 2024
-
ZAGREB: India-Croatia Foreign Office Consultations (FOC) - May 1, 2024
-
BUCHAREST: Government Of Romania To Offer Scholarships To Indian Students - April 30, 2024
-
WASHINGTON: India Now Second-Largest Source Country For New Citizens In US- Report - April 30, 2024
-
LONDON: Run For Modi” Event In London To Drum Up Support For PM Modi - April 29, 2024
-
LONDON: Indian-Origin Candidate On How He Plans To Win London Mayoral Polls - April 28, 2024
-
HARVARD: No Country Is Perfect”: Physics Wallah Urges Indian Students At Harvard, Stanford To Return - April 27, 2024
LOBAMBA : India offers support for Africa to fight the Omicron variant
LOBAMBA : We have noted the emergence of a new variant of Covid-19, Omicron. We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant.
The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines. Supplies can be undertaken through COVAX or bilaterally. In this regard, the Government has cleared all orders placed so far by COVAX for supplies of COVISHIELD vaccines including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. We have also cleared supplies of COVAXIN to Botswana. Any new requirement projected either bilaterally or through COVAX will be considered expeditiously.
India also stands ready to supply essential life-saving drugs, test kits, gloves, PPE kits and medical equipment such as ventilators, as may be required. Indian institutions would favourably consider cooperation in genomic surveillance and virus characterization related research work with their African counterparts.
India has, so far, supplied more than 25 million doses of Made-in-India vaccines to 41 countries in Africa, including nearly 1 million doses as grant to 16 countries and more than 16 million doses under the COVAX facility to 33 countries.]